Kidney cancer mortality statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Deaths

Deaths from kidney cancer, 2015-2017, UK.

Percentage of all deaths

Percentage kidney cancer contributes to total cancer deaths, 2015-2017, UK

Age

Peak mortality rate for kidney cancer, 2015-2017, UK

Trend over time

Change in kidney cancer mortality rates since the early 1970s, UK

Kidney cancer is the 13th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2017).[1-3]

In females in the UK, kidney cancer is the 14th most common cause of cancer death (2% of all female cancer deaths). In males in the UK it is the 12th most common cause of cancer death (3% of all male cancer deaths).

38% of kidney cancer deaths in the UK are in females, and 62% are in males.

Kidney cancer mortality rates (European age-standardised (AS) rates) Open a glossary item for persons are significantly higher than the UK average in Scotland, and similar to the UK average in all other UK constituent countries.

Kidney Cancer (C64-C66,C68), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2017

  England Scotland Wales Northern Ireland UK
Female Deaths 1,451 191 91 26 1,759
Crude Rate 5.2 6.9 5.7 2.7 5.3
AS Rate 5.0 6.5 5.0 3.0 5.1
AS Rate - 95% LCL 4.8 5.6 4.0 1.8 4.9
AS Rate - 95% UCL 5.3 7.4 6.1 4.1 5.3
Male Deaths 2,332 272 149 79 2,832
Crude Rate 8.5 10.3 9.7 8.6 8.7
AS Rate 10.1 12.0 10.3 11.0 10.3
AS Rate - 95% LCL 9.7 10.6 8.6 8.6 9.9
AS Rate - 95% UCL 10.5 13.5 11.9 13.5 10.6
Persons Deaths 3,783 463 240 105 4,591
Crude Rate 6.8 8.5 7.7 5.6 7.0
AS Rate 7.3 8.9 7.4 6.6 7.4
AS Rate - 95% LCL 7.1 8.1 6.5 5.3 7.2
AS Rate - 95% UCL 7.5 9.8 8.3 7.8 7.6

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate  Open a glossary item
 
For kidney cancer, there are mortality differences between countries despite there being no such differences in incidence.

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C64-C66, C68.

Last reviewed:

Kidney cancer mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2015-2017, on average each year more than half (52%) of deaths were in people aged 75 and over.[1-3] This largely reflects higher incidence and lower survival for kidney cancer in older people.

Age-specific mortality rates rise steadily from around age 40-44 and more steeply from around age 65-69. The highest rates are in the 90+ age group for females and males. Mortality rates are significantly lower in females than males in a number of (mainly older) age groups. The gap is widest at age 50 to 54,when the age-specific mortality rate is 2.8 times lower in females than in males.

Kidney Cancer (C64-C66,C68), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Population, UK, 2015-2017

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, ICD-10 C64-C66, C68.

Last reviewed:

Kidney cancer European age-standardised (AS) Open a glossary itemmortality rates for females and males combined increased by 73% in the UK between 1971-1973 and 2015-2017.[1-3] The increase was of a similar size in females and males.

For females, kidney cancer AS mortality rates in the UK increased by 68% between 1971-1973 and 2015-2017. For males, kidney cancer AS mortality rates in the UK increased by 70% between 1971-1973 and 2015-2017.

Over the last decade in the UK (between 2005-2007 and 2015-2017), kidney cancer AS mortality rates for females and males combined increased by 4%. In females AS mortality rates remained stable, and in males rates remained stable.

Kidney Cancer (C64-C66, C68), European Age-Standardised Mortality Rates per 100,000 Population, UK, 1971-2017

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Kidney cancer mortality rates have varied between age groups in females and males combined in the UK since the early 1970s.[1-3] Rates in 0-24s have decreased by 65%, in 25-49s have remained stable, in 50-59s have remained stable, in 60-69s have increased by 29%, in 70-79s have increased by 83%, and in 80+s have increased by 254%.

Kidney Cancer (C64-C66, C68), European Age-Standardised Mortality Rates per 100,000 Population, By Age, UK, 1971-2017

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2017, C64-C66, C68.

Last reviewed:

Kidney cancer mortality rates are projected to fall by 15% in the UK between 2014 and 2035, to 8 deaths per 100,000 people by 2035.[1] This includes a smaller decrease for males than for females.

For males, kidney cancer European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 11% between 2014 and 2035, to 11 deaths per 100,000 by 2035.[1] For females, rates are projected to fall by 27% between 2014 and 2035, to 4 death per 100,000 by 2035.[1]

Kidney cancer (C64-C66, C68), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

 

It is projected that 5,739 deaths from kidney cancer (3,958 in males, 1,781 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C64-C66, C68

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for an association between kidney cancer mortality and deprivation for both males and females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 28% higher for males living in the most deprived areas compared with the least deprived, and 44% higher for females.[1]

Kidney Cancer (C64-C66, C68), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in kidney cancer mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It has been estimated that there would have been around 340 fewer cancer deaths each year in England during 2007-2011 if all people experienced the same mortality rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C64-C66, C68

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.